ID

22553

Description

ODM derived from http://clinicaltrials.gov/show/NCT00275379

Link

http://clinicaltrials.gov/show/NCT00275379

Keywords

  1. 3/6/12 3/6/12 -
  2. 6/7/17 6/7/17 - Martin Dugas
Uploaded on

June 7, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Age 18 Years and older
Description

Legal adult

Data type

boolean

Alias
UMLS CUI [1]
C1706450
Subjects seeking medical treatment for symptoms consistent with IC that have been ongoing for > 9 months or seeking medical treatment for a previous documented diagnosis of IC
Description

Interstitial Cystitis

Data type

boolean

Alias
UMLS CUI [1]
C0282488
Subjects who are not surgically sterile or postmenopausal (amenorrheic > 12 months) must agree and commit to the use of a medically acceptable, highly-effective (i.e. double-barrier or IUD), non-hormonal form of birth control during the study and for 30 days after the last dose of test
Description

birth control

Data type

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Use of herbal supplements (except for a daily multivitamin/mineral supplement not containing herbal components)
Description

Herbal supplements

Data type

boolean

Alias
UMLS CUI [1]
C1504473
History of cancer (other than resected cutaneous basal or squamous cell carcinoma or in situ cervical cancer) with less than 5 years documentation of a disease-free state
Description

History of cancer

Data type

boolean

Alias
UMLS CUI [1]
C2735088
Vaginitis or vaginal infection within 1 month before randomization
Description

Vaginitis or vaginal infection

Data type

boolean

Alias
UMLS CUI [1,1]
C0042267
UMLS CUI [1,2]
C0404521

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Legal adult
Item
Age 18 Years and older
boolean
C1706450 (UMLS CUI [1])
Interstitial Cystitis
Item
Subjects seeking medical treatment for symptoms consistent with IC that have been ongoing for > 9 months or seeking medical treatment for a previous documented diagnosis of IC
boolean
C0282488 (UMLS CUI [1])
birth control
Item
Subjects who are not surgically sterile or postmenopausal (amenorrheic > 12 months) must agree and commit to the use of a medically acceptable, highly-effective (i.e. double-barrier or IUD), non-hormonal form of birth control during the study and for 30 days after the last dose of test
boolean
C0700589 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Herbal supplements
Item
Use of herbal supplements (except for a daily multivitamin/mineral supplement not containing herbal components)
boolean
C1504473 (UMLS CUI [1])
History of cancer
Item
History of cancer (other than resected cutaneous basal or squamous cell carcinoma or in situ cervical cancer) with less than 5 years documentation of a disease-free state
boolean
C2735088 (UMLS CUI [1])
Vaginitis or vaginal infection
Item
Vaginitis or vaginal infection within 1 month before randomization
boolean
C0042267 (UMLS CUI [1,1])
C0404521 (UMLS CUI [1,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial